SCHEMBL6171233

SCHEMBL6171233

CCc1ccnc(C(C)=O)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ASPH Q12797 1/20 0.42
KDM8 Q8N371 1/20 0.42
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
AURKA O14965 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
FYN P06241 1/20 0.34
RET P07949 1/20 0.34
LTK P29376 1/20 0.34
KDR P35968 1/20 0.34
MAPK8 P45983 1/20 0.34
CSNK1A1 P48729 1/20 0.34
CDK8 P49336 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
CDK7 P50613 1/20 0.34
CDK9 P50750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170563 0.81 KDM4E (0.39) KDM4EASPHKDM8GSK3BPRKCI
SCHEMBL6169100 0.79 PDE3B (0.40) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL18988951 0.77 KDM4E (0.44) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL26598072 0.76 KDM4E (0.41) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL31523000 0.76 KDM4E (0.43) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL21561868 0.76 KDM4E (0.43) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL11967121 0.74 NOS3 (0.33) KDM4EASPHKDM8PDE3BPDE3A
SCHEMBL1135178 0.74 LMNA (0.35) KDM4EALDH1A1MAPTAOC3
SCHEMBL6109973 0.73 KDM4E (0.50) KDM4EPDE3BPDE3AALDH1A1CYP1A2
SCHEMBL23326668 0.73 KDM4E (0.41) KDM4EASPHKDM8PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed